查看文章

The BHIVA executive is committed to producing updates on the antiretroviral treatment guidelines for adults on a regular basis. Over a 1-to 2-year period, much can change in clinical practice as new scientific evidence is published. To reflect these changes the guidelines have been extensively revised and some sections removed and new sections added. The sections on co-infection with HIV and hepatitis B or C now form separate guidelines which can be found at the BHIVA website (http://www. bhiva. org). New guidelines on tuberculosis co-infection, paediatric HIV care, and adherence to treatment are also in preparation, while guidelines on the management of HIV and pregnancy will be updated over the coming year.

The principles of consensus that overarched the previous guidelines [3, 4] were upheld in the production of this, the latest version. We believe it is important that the process by which the guidelines have been revised is made clear. As in the previous guidelines each section was designated to two members of BHIVA, and the Executive Committee have taken on the bulk of this work. The members were asked to revise the guidelines in line with new evidence that had been published either in peer reviewed journals or as peer reviewed abstracts at international meetings. The authors were asked to consult widely with colleagues and co-opt other BHIVA members if need be.